Stimwave Technologies and Aspen Medical Products Announce Colloboration

To Enhance Patient Satisfaction Through the Development of Wearable Pain Management Solutions

Stimwave Technologies, the manufacturer of the Freedom Spinal Cord Stimulator (SCS) System, and Aspen Medical Products, the industry leader in solutions for pain and mobility management, today announced a collaboration to develop an innovative wearable pain management accessory for Stimwave’s patients suffering from chronic pain.

“We are constantly looking for ways to improve our therapies’ patient and physician experience. The ability for a chronic pain patient to actively participate in their care, alongside their doctor is a critical component in improving their quality of life,” said Aure Bruneau, Stimwave Technologies Chief Executive Officer. “Our HF-EMC power transfer technology gives us a unique opportunity to combine our system with Aspen’s deep design experience that millions of patients and clinicians have trusted for decades. Together, we can now provide an improved patient-specific solution. We are also committed to leading in the development of additional therapy options that combine bracing and neuromodulation to deliver the next generation of chronic pain management.”

Stimwave’s Freedom SCS platform is designed to treat chronic pain typically associated with a patient’s back and legs by stimulating nerves along their spine. Unlike other neurostimulator devices on the market, Stimwave’s Freedom SCS therapy is powered wirelessly. To continue to enhance the patient experience with the platform, Stimwave and Aspen have partnered to develop a wearable that comfortably and securely houses the systems’ external components. The new wearable can be worn under clothing, allowing for simplified, discreet, and uninterrupted treatment.

“This partnership allows us to leverage Stimwave Technologies and Aspen’s combined capabilities into one elegant and concise system that helps patients suffering from chronic pain get back to their normal lives faster,” commented Jim Cloar, Aspen’s Chief Executive Officer. “Central to everything we do is the necessity to be a significant part of the puzzle of treating pain and changing lives for the better. We are continually focused on delivering the highest-quality products and solutions that enable pain relief and promote mobility.”

Clinicians are invited to visit the Stimwave Technologies booth (#303) or the Aspen booth (#404) at ASIPP (American Society of Interventional Pain Physicians) May 5-7, 2022 in Las Vegas to find out more. Additionally, please visit www.StimwaveFreedom.com to contact a representative.

Stimwave Technologies Incorporated is a privately held medical device company engaged in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of pain management. www.stimwavefreedom.com

Founded in 1994, Aspen Medical Products, LLC is the industry leader in the development and manufacturing of spinal orthopedics and pain therapy solutions. Designed to restore function and alleviate pain, Aspen’s products address a variety of patient needs across the continuum of care to help them resume activities of daily living. Headquartered in Irvine, California, Aspen has local sales representation throughout the U.S. and internationally. www.aspenmp.com.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”